Mittal, Naveen K.School of Medicine |
|
|
Expertise in pediatric liver transplantation hepatology, intestinal rehabilitation and gastro-intestinal organs (liver, intestine and pancreas) transplantation. |
|
| 9/2014 - Present | Greehey Family Foundation Endowed Chair in Pediatric Gastroenterology | University of Texas Health Science Center at San Antonio, San Antonio, TX |
| 8/2014 - Present | Medical Director | University Health System - Liver Transplant Program, San Antonio, TX |
| 11/2013 - Present | Chief, Division of Pediatric Gastroenterology, Hepatology & Nutrition | University Health System, San Antonio, TX |
| 9/2009 - Present | Professor/Clinical | University of Texas Health Science Center at San Antonio, Pediatrics, San Antonio, TX |
| 6/2009 - Present | Chief, Division of Pediatric Gastroenterology | University of Texas Health Science Center at San Antonio, Pediatrics, San Antonio, TX |
| Year | Degree | Discipline | Institution |
| 1996 | Postdoctoral Fellowship | Pediatric Gastroenterology | The University of Chicago Hospital Chicago , IL |
| 1993 | Residency | Pediatrics | Hahnemann University Hospital Philadelphia , PA |
| 1991 | Clinical Fellowship | Clinical Fellowship in Pedi-Gastroenterology | Bristol Royal Hospital Bristol , U.K. |
| 1990 | Residency | Pediatrics | South Cleveland Hospital, Department of Pediatrics Middleborough , U.K. |
| 1988 | MD | Pediatrics | University of Delhi, Maulana Azad Medical College and Associated Hospitals New Delhi , India |
| 1988 | Residency | Pediatrics | Maulana Azad Medical College and Associated Hospitals New Delhi , India |
| 1985 | Residency | Surgery | Safdarjung Hospital, Department of Surgery New Delhi , India |
| 1985 | Residency | Pediatrics | Safdarjung Hospital, Department of Pediatrics New Delhi , India |
| 1984 | Internship | Pediatrics; Other Medical & Surgical Specialties | University College of Medical Sciences, Safdarjung Hospital New Delhi , India |
| 1983 | BM BS | Medicine | University of Delhi, University College of Medical Sciences New Delhi , India |
Transplant Hepatology; Intestinal transplantation.- Transplant physician with expertise in liver and intestinal failure and transplantation. Expertise in pediatric Liver disease and short bowel syndrome. |
Abstract |
| Antonishek JD, Shiu V, Blanco CL, Mittal N. Genetic Mutation of Microvillus Inclusion Disease-Like Phenotype; 2017 Feb. (Journal of Investigative Medicine). |
| Keller L, Mittal N, Blanco CL. Markers of Liver Disease Remain Elevated in Infants With Severe PNALD While on IV FISH Therapy With and Without Soy-Based Intralipid; 2016 May. (Pediatric Research). |
| Sitabkhan A, Moreira AG, Mittal N, Jacob R, Tragus R, Blanco CL. Severe Allergic Colitis Can Present With Elemental Formula Feeds in Infants with Severe Intestinal Failure: A Case Series; 2016 Feb. (Journal of Investigative Medicine). |
Journal Article |
| Mittal NK. Ledipasvir-Sofosbuvir for 12 Weeks in Children 3 to <6 Years old with Chronic Hepatitis C Hepatology 2019 Jun;. |
Not Specified |
| Mittal NK. Pediatric cholestatic liver disease: Successful transition of care Cleveland Clinic Journal of Medicine 2019 Jul;86(7). |
| Keller LM, Kerecman J, Goodman Z, Mittal N, Blanco CL. Markers of Hepatic Injury Correlate with Histological Changes of Neonatal Parenteral Nutrition Associated Liver Disease Journal of Investigative Medicine 2016 Feb;. |
Private |
|
| Funding Agency | Gilead Sciences, Inc. |
| Title | Chronic Hepatitis B - A Randomized, Double-Blind Evaluation of the Pharmacokinetics, Safety, and Antiviral Efficacy of Tenofovir Alafenamide (TAF) in Children and Adolescent Subjects with Chronic Hepatitis B Virus Infection |
| Status | Active |
| Period | 1/2016 - Present |
| Role | Co-Principal Investigator |
| Grant Detail | |
| Funding Agency | Gilead Sciences, Inc. |
| Title | Hepatitis C Virus Infection - A Long Term Follow-up Registry for Adolescent and Pediatric Subjects Who Received a Gilead Hepatitis C Virus Direct Acting Antiviral (DAA) in Gilead-Sponsored Chronic Hepatitis C Infection Trials |
| Status | Active |
| Period | 1/2016 - Present |
| Role | Co-Principal Investigator |
| Grant Detail | |
| Funding Agency | Gilead Sciences, Inc. |
| Title | Hepatitis C Virus Infection - A Phase 2, Open-Label, Multicenter, Multi-cohort, Single-Arm Study to Investigate the Safety and Efficacy of Sofosbuvir + Ribavirin in Adolescents and Children with Genotype 2 or 3 Chronic HCV Infection |
| Status | Complete |
| Period | 1/2014 - 1/2018 |
| Role | Co-Principal Investigator |
| Grant Detail | |
| Funding Agency | Mirum Pharmaceuticals |
| Title | MRX-502: Randomized Double-blind Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Maralixibat in the Treatment of Subjects with Progressive Familial Intrahepatic Cholestasis (PFIC) |
| Status | Active |
| Period | 6/2019 - Present |
| Role | Co-Investigator |
| Grant Detail | |